• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

年龄相关性黄斑变性

Age-related macular degeneration.

作者信息

O'Shea J G

机构信息

Department of Ophthalmology, University of Birmingham, UK.

出版信息

Postgrad Med J. 1998 Apr;74(870):203-7. doi: 10.1136/pgmj.74.870.203.

DOI:10.1136/pgmj.74.870.203
PMID:9683972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2360874/
Abstract

Macular degeneration is now responsible for approximately 95% of blindness and partial sighted registrations in the UK. This review has been written specifically to make the general medical community of the UK aware of the prevalence and clinical manifestations of aged-related macular degeneration. The review encompasses the risk factors, the disabilities and problems experienced by suffers of the condition and current therapeutic options. Age related macular degeneration increases in prevalence in our community from 0% among people under 55 years old to 18.5% among those 85 years or older. There is a marked female preponderance. The exudative form of the disorder is commoner. Treatment remains supportive for most patients with macular degeneration although a minority will benefit from macular laser photocoagulation.

摘要

在英国，黄斑变性目前约占失明和视力部分受损登记病例的95%。撰写本综述的目的是让英国的普通医学界了解年龄相关性黄斑变性的患病率和临床表现。该综述涵盖了风险因素、该病患者所经历的残疾和问题以及当前的治疗选择。在我们的社区中，年龄相关性黄斑变性的患病率从55岁以下人群中的0%上升到85岁及以上人群中的18.5%。女性明显占多数。该疾病的渗出型更为常见。尽管少数黄斑变性患者将从黄斑激光光凝治疗中获益，但对大多数患者而言，治疗仍以支持性为主。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/7584f8aabf93/postmedj00088-0016-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/66203656a35d/postmedj00088-0013-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/90bc2ba83dc0/postmedj00088-0014-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/8bfa989a5d42/postmedj00088-0014-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/07bf5c7d2b0f/postmedj00088-0014-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/59d5701e21c9/postmedj00088-0014-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/36e9a84c121f/postmedj00088-0015-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/e7f1c1b79459/postmedj00088-0015-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/f5970d370938/postmedj00088-0016-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/7584f8aabf93/postmedj00088-0016-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/66203656a35d/postmedj00088-0013-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/90bc2ba83dc0/postmedj00088-0014-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/8bfa989a5d42/postmedj00088-0014-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/07bf5c7d2b0f/postmedj00088-0014-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/59d5701e21c9/postmedj00088-0014-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/36e9a84c121f/postmedj00088-0015-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/e7f1c1b79459/postmedj00088-0015-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/f5970d370938/postmedj00088-0016-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/971b/2360874/7584f8aabf93/postmedj00088-0016-b.jpg

相似文献

1
Age-related macular degeneration.年龄相关性黄斑变性
Postgrad Med J. 1998 Apr;74(870):203-7. doi: 10.1136/pgmj.74.870.203.
2
Age-related macular degeneration.年龄相关性黄斑变性
Aging (Milano). 1993 Jun;5(3):165-76. doi: 10.1007/BF03324151.
3
Age-Related Macular Degeneration.年龄相关性黄斑变性
Prim Care. 2015 Sep;42(3):377-91. doi: 10.1016/j.pop.2015.05.009.
4
Age-related macular degeneration: update for primary care.年龄相关性黄斑变性：基层医疗的最新进展
Am Fam Physician. 2000 May 15;61(10):3035-42.
5
[Age-related macular degeneration].年龄相关性黄斑变性
Rev Med Brux. 2014 Sep;35(4):265-70.
6
Age-related macular degeneration: a leading cause of blindness.年龄相关性黄斑变性：失明的主要原因。
Med J Aust. 1996 Nov 18;165(10):561-4.
7
[Age-related macular degeneration; therapeutic options].[年龄相关性黄斑变性；治疗选择]
Ned Tijdschr Geneeskd. 2001 Jul 21;145(29):1390-7.
8
Exudative age-related macular degeneration in patients with diabetic retinopathy and its relation to retinal laser photocoagulation.糖尿病视网膜病变患者的渗出性年龄相关性黄斑变性及其与视网膜激光光凝的关系。
Eye (Lond). 1997;11 ( Pt 6):872-5. doi: 10.1038/eye.1997.224.
9
Management of age-related macular degeneration.年龄相关性黄斑变性的管理
J Indian Med Assoc. 2003 Aug;101(8):471-4, 476.
10
[Age-related macular degeneration].年龄相关性黄斑变性
Rev Prat. 2006 Jun 15;56(11):1194-201.

引用本文的文献

1
The role of CRP and inflammation in the pathogenesis of age-related macular degeneration.C 反应蛋白及炎症在年龄相关性黄斑变性发病机制中的作用。
Biochem Med (Zagreb). 2012;22(1):39-48. doi: 10.11613/bm.2012.005.
2
Normal aging involves modulation of specific inflammatory markers in the rat retina and choroid.正常衰老涉及大鼠视网膜和脉络膜中特定炎症标志物的调节。
J Gerontol A Biol Sci Med Sci. 2009 Mar;64(3):325-31. doi: 10.1093/gerona/gln052. Epub 2009 Jan 30.
3
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration.

本文引用的文献

1
Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.澳大利亚年龄相关性黄斑病变的患病率。蓝山眼研究。
Ophthalmology. 1995 Oct;102(10):1450-60. doi: 10.1016/s0161-6420(95)30846-9.
2
Is the incidence of registrable age-related macular degeneration increasing?可登记的年龄相关性黄斑变性的发病率在上升吗？
Br J Ophthalmol. 1996 Jan;80(1):9-14. doi: 10.1136/bjo.80.1.9.
3
Sunlight and age-related macular degeneration. The Beaver Dam Eye Study.阳光与年龄相关性黄斑变性。比弗迪姆眼研究。
采用抗血管内皮生长因子疗法治疗新生血管性年龄相关性黄斑变性的抗血管生成治疗
Cochrane Database Syst Rev. 2008 Apr 16(2):CD005139. doi: 10.1002/14651858.CD005139.pub2.
4
Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL).黄斑疾病对生活质量影响的个体化测量方法（MacDQoL）的设计。
Qual Life Res. 2004 Aug;13(6):1163-75. doi: 10.1023/B:QURE.0000031348.51292.4a.
5
Psychometric evaluation of the 12-item Well-being Questionnaire for use with people with macular disease.用于黄斑疾病患者的12项幸福感问卷的心理测量评估。
Qual Life Res. 2001;10(5):465-73. doi: 10.1023/a:1012540100613.
6
Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration.年龄相关性黄斑变性中深层视网膜血管异常复合体的临床病理相关性
Br J Ophthalmol. 2000 Nov;84(11):1269-74. doi: 10.1136/bjo.84.11.1269.
Arch Ophthalmol. 1993 Apr;111(4):514-8. doi: 10.1001/archopht.1993.01090040106042.
4
The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study.心血管疾病及其危险因素与年龄相关性黄斑病变的关系。比弗迪尔姆眼科研究。
Ophthalmology. 1993 Mar;100(3):406-14. doi: 10.1016/s0161-6420(93)31634-9.
5
The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking.比弗迪姆眼研究：年龄相关性黄斑病变与吸烟的关系。
Am J Epidemiol. 1993 Jan 15;137(2):190-200. doi: 10.1093/oxfordjournals.aje.a116659.
6
Prevalence of age related macular degeneration in persons aged 50 years and over resident in Australia.澳大利亚50岁及以上居民年龄相关性黄斑变性的患病率。
J Epidemiol Community Health. 1993 Feb;47(1):42-5. doi: 10.1136/jech.47.1.42.
7
Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment.年龄相关性布鲁赫膜改变：遗传与环境相对作用的临床研究
Br J Ophthalmol. 1993 Jul;77(7):400-3. doi: 10.1136/bjo.77.7.400.
8
Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study.远距离治疗年龄相关性黄斑中心凹下新生血管膜的初步研究。
Br J Ophthalmol. 1993 May;77(5):265-73. doi: 10.1136/bjo.77.5.265.
9
The prevalence of eye disease in Leicester: a comparison of adults of Asian and European descent.莱斯特眼病患病率：亚裔与欧洲裔成年人的比较。
J R Soc Med. 1994 Apr;87(4):219-22.
10
Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study.年龄相关性黄斑病变的同胞相关性及分离分析：比弗迪尔眼研究
Genet Epidemiol. 1994;11(1):51-67. doi: 10.1002/gepi.1370110106.